Case Series on Rifampicin-induced Thrombocytopenia with Daily Regimen: Clinical Insights and Management Strategies

Thrombocytopenia, a rare but serious complication of rifampicin treatment, underscores the importance of timely intervention to prevent adverse outcomes.This article offers a detailed exploration of rifampicin-induced thrombocytopenia, shedding light on its causes, symptoms, diagnosis, and treatment options.Through a blend of research insights and real-life cases, we emphasize the crucial role of healthcare providers in recognizing and addressing this condition promptly.By advocating for increased awareness and vigilant monitoring, we aim to ensure the safety and well-being of patients undergoing anti-tuberculosis treatment.